Literature DB >> 11308840

Particle-counterion clustering in highly charge-asymmetric complex fluids.

A Fernández-Nieves1, A Fernández-Barbero, F J de las Nieves.   

Abstract

The formation of particle-counterion clusters through electrostatic interaction is studied in this work for a highly charge asymmetric colloidal suspension. The occurrence of such clustering is probed by the particle electrophoretic mobility, i.e., with the aid of a transport property. The results show that the effective charge manifesting under the presence of an external electric field is the renormalized charge predicted by an extension of the Debye-Hückel-Bjerrum theory to the fluid state of highly charged colloids.

Mesh:

Substances:

Year:  2001        PMID: 11308840     DOI: 10.1103/PhysRevE.63.041404

Source DB:  PubMed          Journal:  Phys Rev E Stat Nonlin Soft Matter Phys        ISSN: 1539-3755


  4 in total

1.  Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.

Authors:  Suraj Dixit; Kayla Miller; Yun Zhu; Emilie McKinnon; Thomas Novak; Malcolm E Kenney; Ann-Marie Broome
Journal:  Mol Pharm       Date:  2015-08-24       Impact factor: 4.939

2.  Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates.

Authors:  Kye-Il Joo; Yun Fang; Yarong Liu; Liang Xiao; Zhen Gu; April Tai; Chi-Lin Lee; Yi Tang; Pin Wang
Journal:  ACS Nano       Date:  2011-04-13       Impact factor: 15.881

3.  Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.

Authors:  Suraj Dixit; Thomas Novak; Kayla Miller; Yun Zhu; Malcolm E Kenney; Ann-Marie Broome
Journal:  Nanoscale       Date:  2015-02-07       Impact factor: 7.790

4.  Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.

Authors:  Kayla Miller; Suraj Dixit; Amy-Lee Bredlau; Alfred Moore; Emilie McKinnon; Ann-Marie Broome
Journal:  Nanomedicine (Lond)       Date:  2016-03-22       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.